Development of a novel cell-free DNA fragmentomics assay for monitoring disease progression in real-time for stage IV cancer patients. This is an ASCO Meeting Abstract from the 2024 ASCO Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results